The AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +1.05% inched 0.52% higher to $58.40 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +3.33% rising 0.23% to 15,188.39 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.76% rising 0.11% to 36,290.32. This was the ADR's fourth consecutive day of gains. AstraZeneca PLC ADR closed $5.81 below its 52-week high ($64.21), which the company reached on November 2nd.
The ADR outperformed some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.38% rose 0.23% to $137.29, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.87% fell 0.27% to $231.76, and Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.51% fell 0.17% to $72.25. Trading volume (3.5 M) remained 1.3 million below its 50-day average volume of 4.8 M.